Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19038009

Download in:

View as

General Info

PMID
19038009